Experimental Drug May Prompt Weight-Loss In Obese Mice.

Science Now” blog reports that research suggests that “a variant of a drug used to treat pulmonary arterial hypertension prompts weight-loss in obese mice.” Researchers found that “among mice fed a high-fat diet, those who did not get the medication became obese while medicated mice did not.” The blog points out that “the experimental drug used, a stimulator of soluble guanylyl cyclase (sGC), is a member of the same class of novel drugs as the drug riociguat.”